These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 14739160

  • 1. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
    van Rooij E, Doevendans PA, Crijns HJ, Heeneman S, Lips DJ, van Bilsen M, Williams RS, Olson EN, Bassel-Duby R, Rothermel BA, De Windt LJ.
    Circ Res; 2004 Feb 20; 94(3):e18-26. PubMed ID: 14739160
    [Abstract] [Full Text] [Related]

  • 2. Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.
    Niizeki T, Takeishi Y, Arimoto T, Takahashi H, Shishido T, Koyama Y, Goto K, Walsh RA, Kubota I.
    Am J Physiol Heart Circ Physiol; 2007 Feb 20; 292(2):H1105-12. PubMed ID: 17071729
    [Abstract] [Full Text] [Related]

  • 3. Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc.
    Heineke J, Ruetten H, Willenbockel C, Gross SC, Naguib M, Schaefer A, Kempf T, Hilfiker-Kleiner D, Caroni P, Kraft T, Kaiser RA, Molkentin JD, Drexler H, Wollert KC.
    Proc Natl Acad Sci U S A; 2005 Feb 01; 102(5):1655-60. PubMed ID: 15665106
    [Abstract] [Full Text] [Related]

  • 4. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
    Du XJ, Gao XM, Kiriazis H, Moore XL, Ming Z, Su Y, Finch AM, Hannan RA, Dart AM, Graham RM.
    Cardiovasc Res; 2006 Sep 01; 71(4):735-43. PubMed ID: 16859660
    [Abstract] [Full Text] [Related]

  • 5. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD.
    Circ Res; 2004 May 14; 94(9):1256-62. PubMed ID: 15044322
    [Abstract] [Full Text] [Related]

  • 6. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T, Horio T, Kishimoto I, Soeki T, Mori K, Kawano Y, Kohno M, Garbers DL, Nakao K, Kangawa K.
    Circulation; 2005 Jun 14; 111(23):3095-104. PubMed ID: 15939815
    [Abstract] [Full Text] [Related]

  • 7. Doppler echocardiographic assessment and cardiac gene expression analysis of the left ventricle in myocardial infarcted rats.
    Shimizu N, Yoshiyama M, Takeuchi K, Hanatani A, Kim S, Omura T, Iwao H, Yoshikawa J.
    Jpn Circ J; 1998 Jun 14; 62(6):436-42. PubMed ID: 9652320
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, Wen J, Kubota T, Utsumi H, Takeshita A.
    Circulation; 2004 Feb 03; 109(4):544-9. PubMed ID: 14744974
    [Abstract] [Full Text] [Related]

  • 9. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ, Scott NJ, Cameron VA, Richards AM, Rademaker MT.
    J Cardiovasc Pharmacol; 2015 Mar 03; 65(3):269-75. PubMed ID: 25658462
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Matsushima S, Ide T, Yamato M, Matsusaka H, Hattori F, Ikeuchi M, Kubota T, Sunagawa K, Hasegawa Y, Kurihara T, Oikawa S, Kinugawa S, Tsutsui H.
    Circulation; 2006 Apr 11; 113(14):1779-86. PubMed ID: 16585391
    [Abstract] [Full Text] [Related]

  • 11. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.
    Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, Liaw L, Jenkins AW, Wang J, Sawyer DB, Bing OH, Apstein CS, Colucci WS, Singh K.
    Circ Res; 2001 May 25; 88(10):1080-7. PubMed ID: 11375279
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
    Li Q, Xu Y, Li X, Guo Y, Liu G.
    Toxicol Lett; 2012 Jun 01; 211(2):91-7. PubMed ID: 22465603
    [Abstract] [Full Text] [Related]

  • 13. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo.
    Rothermel BA, McKinsey TA, Vega RB, Nicol RL, Mammen P, Yang J, Antos CL, Shelton JM, Bassel-Duby R, Olson EN, Williams RS.
    Proc Natl Acad Sci U S A; 2001 Mar 13; 98(6):3328-33. PubMed ID: 11248078
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of apolipoprotein B attenuates pathologic cardiac remodeling and hypertrophy in response to catecholamines and after myocardial infarction in mice.
    Råmunddal T, Lindbom M, Täng MS, Shao Y, Borén J, Omerovic E.
    Scand J Clin Lab Invest; 2012 May 13; 72(3):230-6. PubMed ID: 22283829
    [Abstract] [Full Text] [Related]

  • 15. Influence of sex on ventricular remodeling after myocardial infarction in mice.
    Wu JC, Nasseri BA, Bloch KD, Picard MH, Scherrer-Crosbie M.
    J Am Soc Echocardiogr; 2003 Nov 13; 16(11):1158-62. PubMed ID: 14608287
    [Abstract] [Full Text] [Related]

  • 16. Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction.
    Gidh-Jain M, Huang B, Jain P, Gick G, El-Sherif N.
    J Mol Cell Cardiol; 1998 Mar 13; 30(3):627-37. PubMed ID: 9515038
    [Abstract] [Full Text] [Related]

  • 17. Effects of the vasopeptidase inhibitor omapatrilat on peri- and postmyocardial infarction in Zucker lean rats.
    Lapointe N, Parker TG, Tsoporis JN, Nguyen QT, Marcotte F, Adam A, Lou I, Rouleau JL.
    Can J Cardiol; 2005 Mar 13; 21(3):291-7. PubMed ID: 15776120
    [Abstract] [Full Text] [Related]

  • 18. Biglycan is required for adaptive remodeling after myocardial infarction.
    Westermann D, Mersmann J, Melchior A, Freudenberger T, Petrik C, Schaefer L, Lüllmann-Rauch R, Lettau O, Jacoby C, Schrader J, Brand-Herrmann SM, Young MF, Schultheiss HP, Levkau B, Baba HA, Unger T, Zacharowski K, Tschöpe C, Fischer JW.
    Circulation; 2008 Mar 11; 117(10):1269-76. PubMed ID: 18299507
    [Abstract] [Full Text] [Related]

  • 19. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice.
    Riad A, Jäger S, Sobirey M, Escher F, Yaulema-Riss A, Westermann D, Karatas A, Heimesaat MM, Bereswill S, Dragun D, Pauschinger M, Schultheiss HP, Tschöpe C.
    J Immunol; 2008 May 15; 180(10):6954-61. PubMed ID: 18453617
    [Abstract] [Full Text] [Related]

  • 20. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C, Grote K, Hilfiker-Kleiner D, Luchtefeld M, Schaefer A, Holland SM, Sorrentino S, Manes C, Schieffer B, Drexler H, Landmesser U.
    Circ Res; 2007 Mar 30; 100(6):894-903. PubMed ID: 17332431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.